Curated Information

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home

Curated Information Page

PubMed Id: 16306348

This page summarizes selected information from the article referenced above and curated into PhosphoSitePlus^®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2012,40:D261-70). To learn more about the scope of PhosphoSitePlus^®, click here.

Freude S, et al. (2005) Peripheral hyperinsulinemia promotes tau phosphorylation in vivo. Diabetes 54, 3343-8 16306348

Only sites from this record are displayed on this page. Click on the protein name to open the protein page, and on the RSD number to open the site page. For the complete dataset, click the download button, on the right.

S494-p - tau (mouse)

▲

Orthologous residues

tau (human): S519‑p, tau iso2 (human): S144‑p, tau iso3 (human): S108‑p, tau iso5 (human): S202‑p, tau iso6 (human): S144‑p, tau iso8 (human): S202‑p, tau (mouse): S494‑p, tau iso3 (mouse): S191‑p, tau iso7 (mouse): S151‑p, tau (rat): S513‑p, tau (cow): S209‑p

Characterization

Methods used to characterize site in vivo: phospho-antibody

Cellular systems studied: tissue

Species studied: mouse

Upstream Regulation

Treatments, proteins and their effect on site modification:

Treatments	Referenced Treatments	Manipulated Protein	Referenced Protein	Effect	Notes
insulin		InsR (mouse)		increase

T523-p - tau (mouse)

▲